Elevance Health (ELV) FY2012 results: revenue $61.5 billion, up 1.3% on the year
Elevance Health, Inc. (ELV) reported revenue of $61.5 billion for fiscal 2012, the year ended 31 December 2012, up 1.3% on the year before. Net income was $2.7 billion, up 0.3%, and diluted earnings per share $8.18. The figures are the company's own, from the 10-K it filed with the SEC on 22 February 2013.
Revenue
$61.5 billion
+1.3% on the year
FY2007FY2012
Operating margin
5.9%
6.2% a year earlier
FY2007FY2012
Net income
$2.7 billion
+0.3% on the year
FY2007FY2012
Diluted EPS
$8.18
+12.8% on the year
FY2007FY2012
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Revenue
61,497
60,711
58,802
+1.3%
Cost of revenue
137
0.0
0.0
Gross profit
n/a
60,711
58,802
Gross margin
n/a
100.0%
100.0%
Selling, general and administrative
8,680
8,436
8,733
+2.9%
Operating income
3,620
3,782
4,078
-4.3%
Operating margin
5.9%
6.2%
6.9%
Interest expense
512
430
419
+18.9%
Pre-tax income
3,858
3,958
4,354
-2.5%
Income tax
1,207
1,311
1,467
-7.9%
Effective tax rate
31.3%
33.1%
33.7%
Net income
2,656
2,647
2,887
+0.3%
Net margin
4.3%
4.4%
4.9%
Diluted EPS
$8.18
$7.25
$6.94
+12.8%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Operating cash flow
2,745
3,374
1,417
-18.7%
Capital expenditure
545
520
451
+4.9%
Free cash flow
2,200
2,855
965
-23.0%
Free cash flow margin
3.6%
4.7%
1.6%
Cash from investing
-4,552
-942
-1,272
Cash from financing
2,089
-2,019
-3,169
Depreciation and amortisation
340
335
345
+1.5%
Share-based compensation
146
135
136
+8.7%
Buybacks
2,497
3,040
4,360
-17.9%
Dividends paid
367
358
0.0
+2.6%
Dividend per share
$1.15
$1.00
$0.00
+15.0%
Diluted shares, weighted
325m
365m
416m
-11.0%
Shares outstanding at period end
305m
339m
378m
-10.2%
Balance sheet
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Shareholders' equity
23,803
23,288
23,813
+2.2%
Debt
14,978
9,840
8,954
+52.2%
Other liabilities
20,175
19,035
17,401
+6.0%
Total liabilities and equity
58,955
52,163
50,167
+13.0%
Fixed assets
1,717
1,418
1,156
+21.1%
Goodwill
16,890
13,859
13,265
+21.9%
Intangible assets
8,666
7,932
7,997
+9.3%
Investments
17,344
16,160
16,291
+7.3%
Cash and equivalents
2,475
2,202
1,789
+12.4%
Other assets
11,863
10,593
9,670
+12.0%
Total assets
58,955
52,163
50,167
+13.0%
10-K for the year ended 31 December 2012, filed 22 February 2013: the filing.